The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease.

The article reports on the study that determines the incidence of hyperkalemia in chronic kidney disease (CKD). It found that the adjusted rate of hyperkalemia was higher in patients with CKD than those without CKD among individuals treated with renin-angiotensin-aldosterone system (RAAS) blokers. It also reveals that the adjusted odds ratio of death with a moderate and severe hyperkalemia event was highest with no CKD. It suggests that the risk of hyperkalemia in increased with CKD and its occurrence increases the odds of mortality within one day of event.